Lan Y, Jing X, Zhou Z, Rao Y, Wang K, Qin R
Chin Med. 2024; 19(1):176.
PMID: 39719630
PMC: 11667860.
DOI: 10.1186/s13020-024-01048-z.
Jiang H, Xing X, Zhu H, Dong T
China CDC Wkly. 2024; 6(25):589-596.
PMID: 38933042
PMC: 11196880.
DOI: 10.46234/ccdcw2024.115.
Moyo P, Merlin J, Gairola R, Girard A, Shireman T, Trivedi A
J Gen Intern Med. 2024; 39(11):2097-2105.
PMID: 38829451
PMC: 11306843.
DOI: 10.1007/s11606-024-08799-3.
Kufeld N, Weckbecker K, Michalak J, Hauser W, Petzke F, Scherbaum N
J Pain Res. 2024; 17:873-885.
PMID: 38476877
PMC: 10929247.
DOI: 10.2147/JPR.S445153.
Wu J, Hua L, Liu W, Yang X, Tang X, Yuan S
Mol Neurobiol. 2023; 61(5):2949-2963.
PMID: 37957422
PMC: 11043129.
DOI: 10.1007/s12035-023-03760-7.
Association of Opioid Use Disorder Diagnosis With Use of Physical Therapy and Chiropractic Care Among Chronic Low Back Pain Patients: A Group-Based Trajectory Analysis.
Moyo P, Merlin J, George M, Shireman T, Marshall B
J Pain. 2023; 25(3):742-754.
PMID: 37820847
PMC: 10922407.
DOI: 10.1016/j.jpain.2023.10.003.
U-PAIN cohort study among patients with chronic pain in specialised pain care: a feasibility study.
Ljungvall H, Lind A, Zetterberg H, Wagner S, Ekselius L, Karlsten R
BMJ Open. 2022; 12(12):e062265.
PMID: 36517106
PMC: 9756188.
DOI: 10.1136/bmjopen-2022-062265.
Trends in the Prescription of Strong Opioids for Chronic Non-Cancer Pain in Primary Care in Catalonia: Opicat-Padris-Project.
Perello-Bratescu A, Dursteler C, Alvarez-Carrera M, Granes L, Kostov B, Siso-Almirall A
Pharmaceutics. 2022; 14(2).
PMID: 35213969
PMC: 8876214.
DOI: 10.3390/pharmaceutics14020237.
[Critical discussion of new data regarding prevalence of opioid use disorder in patients with chronic pain in Germany].
Just J, Petzke F, Scherbaum N, Radbruch L, Weckbecker K, Hauser W
Schmerz. 2021; 36(1):13-18.
PMID: 34505947
PMC: 8821065.
DOI: 10.1007/s00482-021-00582-1.
Chronic Noncancer Pain and Opioid Addiction: Diagnostic and Management Challenges.
Kathiresan P, Rao R, Joshi T, Bhad R, Bhatnagar S, Deb K
Indian J Palliat Care. 2021; 26(4):544-547.
PMID: 33623322
PMC: 7888418.
DOI: 10.4103/IJPC.IJPC_232_19.
Opioid Medication Use Among Chronic Non-Cancer Pain Patients Assessed with a Modified Drug Effects Questionnaire and the Association with Opioid Use Disorder.
Boscarino J, Withey C, Dugan R, Hu Y, Auciello J, Alfieri T
J Pain Res. 2020; 13:2697-2705.
PMID: 33122939
PMC: 7591039.
DOI: 10.2147/JPR.S275397.
Health outcomes and costs in patients with osteoarthritis and chronic pain treated with opioids in Spain: the OPIOIDS real-world study.
Sicras-Mainar A, Tornero-Tornero C, Vargas-Negrin F, Lizarraga I, Rejas-Gutierrez J
Ther Adv Musculoskelet Dis. 2020; 12:1759720X20942000.
PMID: 32994809
PMC: 7502862.
DOI: 10.1177/1759720X20942000.
Case Series: Limited Opioid Withdrawal With Use of Transdermal Buprenorphine to Bridge to Sublingual Buprenorphine in Hospitalized Patients.
Tang V, Lam-Shang-Leen J, Brothers T, Hansen K, Caudarella A, Lamba W
Am J Addict. 2019; 29(1):73-76.
PMID: 31626394
PMC: 7134509.
DOI: 10.1111/ajad.12964.
Strategies to Identify Patient Risks of Prescription Opioid Addiction When Initiating Opioids for Pain: A Systematic Review.
Klimas J, Gorfinkel L, Fairbairn N, Amato L, Ahamad K, Nolan S
JAMA Netw Open. 2019; 2(5):e193365.
PMID: 31050783
PMC: 6503484.
DOI: 10.1001/jamanetworkopen.2019.3365.
Evaluation of US Food and Drug Administration-recommended abuse-potential questions in chronic pain patients without history of recreational opioid use: results and plan for research.
Boscarino J, Withey C, Dugan R, Alfieri T
J Pain Res. 2018; 12:9-15.
PMID: 30588075
PMC: 6301309.
DOI: 10.2147/JPR.S176950.
